Numinus Wellness, Inc. (NUMIF)
0.0207
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Numinus Wellness EPS Diluted (Quarterly) : -0.0007 for May 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.0007 |
| February 28, 2026 | -0.0003 |
| November 30, 2025 | -0.0005 |
| August 31, 2025 | 0.0174 |
| May 31, 2025 | -0.0017 |
| February 28, 2025 | -0.0218 |
| November 30, 2024 | -0.003 |
| August 31, 2024 | -0.008 |
| May 31, 2024 | -0.016 |
| February 29, 2024 | -0.0168 |
| November 30, 2023 | -0.0123 |
| August 31, 2023 | -0.0263 |
| May 31, 2023 | -0.0256 |
| February 28, 2023 | -0.0209 |
| November 30, 2022 | -0.018 |
| August 31, 2022 | -0.0853 |
| May 31, 2022 | -0.0262 |
| February 28, 2022 | -0.03 |
| November 30, 2021 | -0.021 |
| August 31, 2021 | -0.0308 |
| May 31, 2021 | -0.02 |
| February 28, 2021 | -0.0222 |
| November 30, 2020 | -0.013 |
| August 31, 2020 | -0.0256 |
| May 31, 2020 | -0.0253 |
| Date | Value |
|---|---|
| January 31, 2020 | -0.0152 |
| October 31, 2019 | -0.0044 |
| July 31, 2019 | -0.0158 |
| April 30, 2019 | -0.0067 |
| January 31, 2019 | -0.0142 |
| October 31, 2018 | -0.0056 |
| July 31, 2018 | -0.0321 |
| April 30, 2018 | -0.0348 |
| January 31, 2018 | -0.027 |
| October 31, 2017 | 0.0064 |
| July 31, 2017 | -0.0606 |
| April 30, 2017 | 0.015 |
| January 31, 2017 | -0.0233 |
| October 31, 2016 | -0.0239 |
| July 31, 2016 | -0.0231 |
| April 30, 2016 | -0.0171 |
| January 31, 2016 | -0.0197 |
| October 31, 2015 | -0.7831 |
| July 31, 2015 | -0.0053 |
| April 30, 2015 | -0.0729 |
| January 31, 2015 | -0.0844 |
| October 31, 2014 | -0.0724 |
| July 31, 2014 | -0.2218 |
| April 30, 2014 | -0.362 |
| January 31, 2014 | -0.374 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.2295 |
| Edesa Biotech, Inc. | -0.6003 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Invion Ltd. | -- |
| ProMIS Neurosciences, Inc. | -1.283 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1881M |
| Revenue (Quarterly) | 1.171M |
| Total Expenses (Quarterly) | 1.359M |
| Enterprise Value | 7.475M |
| Gross Profit Margin (Quarterly) | 51.16% |
| Profit Margin (Quarterly) | -16.07% |
| Earnings Yield | 76.70% |
| Normalized Earnings Yield | 81.04 |